CRISPR Investments: Potential vs Reality

The Transformative Era of CRISPR: Navigating the Investment Landscape

Over the past decade, the CRISPR technology landscape has undergone a dramatic transformation, fueled by significant investment from both private and public sectors. With an astounding $4 to $6 billion injected into start-ups focusing on CRISPR applications in agriculture, and an equivalent or even greater sum by seed companies for gene editing in crops, the financial commitment to this revolutionary technology is evident. The public sector has not lagged behind, with research into plant gene editing also receiving substantial backing, as evidenced by 53 USDA exemptions for gene-edited traits across approximately 17 crops as of January.